Benperidol
NERVOUS SYSTEM
Also known as: benzoperidol, benzperidol, frenactil, frenactyl, glianimon
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Benperidol is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1965. DrugCentral lists 6 molecular targets, including DRD2, DRD3 and HTR2A. Recorded indications include Antisocial behavior.
- Molecular targets: DRD2, DRD3, HTR2A and DRD4 (6 listed in DrugCentral).
- Indications: Antisocial behavior.
- ATC code: N05AD07 (Butyrophenone derivatives).
- Molecular formula: C22H24FN3O2; molecular weight 381.45 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Antisocial behavior
Mechanism & targets
Molecular targets (6)
| Target | Gene | Action | Activity |
|---|---|---|---|
| D(2) dopamine receptor | DRD2 | unknown | Ki 10.57 |
| D(3) dopamine receptor | DRD3 | unknown | Ki 10.18 |
| 5-hydroxytryptamine receptor 2A | HTR2A | unknown | Ki 9.00 |
| D(4) dopamine receptor | DRD4 | unknown | Ki 8.70 |
| Potassium voltage-gated channel subfamily H member 2 | KCNH2 | unknown | IC50 8.47 |
| Sigma non-opioid intracellular receptor 1 | SIGMAR1 | unknown | EC50 5.94 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1965-01-01 | YEAR INTRODUCED | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N05AD07 | NERVOUS SYSTEM › PSYCHOLEPTICS › ANTIPSYCHOTICS › Butyrophenone derivatives |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Neuroleptic malignant syndrome | 162.1 |
| Psychotic symptom | 101.8 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Benperidol is on its molecule page.
| Molecular formula | C22H24FN3O2 |
|---|---|
| Molecular weight | 381.45 g/mol |
| CAS number | 2062-84-2 |
| InChIKey | FEBOTPHFXYHVPL-UHFFFAOYSA-N |
| PubChem CID | 16363 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Benperidol used for?
DrugCentral lists the following indications for Benperidol: Antisocial behavior.
How does Benperidol work?
Its molecular targets in DrugCentral include DRD2, DRD3, HTR2A and DRD4.
When was Benperidol first approved?
Benperidol was first approved by the YEAR INTRODUCED in 1965.
What is the chemical formula of Benperidol?
Benperidol has the molecular formula C22H24FN3O2 and a molecular weight of 381.45 g/mol.
Browse: all drugs starting with B · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 312 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL297302 — compound record and bioactivity
- PubChem CID 16363 — chemical identifiers
- DrugBank DB12867 — drug record
- FDA UNII 97O6X78C53 — substance identity
- UniProt P14416 (DRD2) — target protein
- UniProt P35462 (DRD3) — target protein
- UniProt P28223 (HTR2A) — target protein
- UniProt P21917 (DRD4) — target protein
- UniProt Q12809 (KCNH2) — target protein
- UniProt Q99720 (SIGMAR1) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.